Abstract
Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have